Dr. Michael Chevinsky

Dr. Michael Chevinsky
Dr. Michael S. Chevinsky was born on Long Island, New York and although he grew up next door in New Jersey, he often returned to visit his aunts, uncles, cousins, and grandparents on Long Island. He received a Bachelor of Arts degree in Neurosciences with a minor in Philosophy from Drew University, in Madison, New Jersey. He graduated Summa Cum Laude and was inducted into the Phi Beta Kappa national academic honor society, Beta Beta Beta national biology honor society, and Nu Rho Psi national neuroscience honor society. Dr. Chevinsky then attended Rutgers Robert Wood Johnson Medical School in New Brunswick, New Jersey, where he received a medical degree with a distinction in research. During medical school, Dr. Chevinsky pursued his interest in urology at the prestigious Memorial Sloan Kettering Cancer Center in New York City, dedicating an additional year of study focusing his attention on better understanding urologic cancers. Continuing his medical career at the renowned Washington University in St. Louis-Barnes Jewish Hospital Medical Center in St. Louis, Missouri, Dr. Chevinsky completed a one-year general surgery internship followed by four years of residency training in adult and pediatric urologic surgery. While serving as Chief Resident, Dr. Chevinsky had the opportunity to participate in many different complex urologic surgeries utilizing open, laparoscopic, and robotic surgical techniques. Following residency, Dr. Chevinsky was selected for a highly coveted fellowship position in Robotic Urologic Oncology and Minimally Invasive Surgery at The University of Southern California Institute of Urology, where he participated in over 200 robotic urologic surgeries. Upon completion of his fellowship, Dr. Michael Chevinsky cared for patients in and around Orange County, helping to grow a busy private urologic practice in Southern California. Understanding the need for health education, he regularly volunteered his time at community health fairs and participated in prostate cancer screening events. He authored and co-authored more than 35 articles in highly regarded journals including Nature Communications, The Journal of Clinical Oncology, and The Journal of Urology, as well as presenting at numerous national meetings. His journal articles and abstracts have been cited over 450 times. Dr. Chevinsky, a board certified urologist, has trained in the newest techniques and technologies for a broad spectrum of urologic conditions, including Da Vinci robotic surgery for urologic cancers as well as for benign indications, minimally invasive treatments for kidney stones and ureteral strictures, robotic simple prostatectomy, GreenLight™ Laser Therapy vaporization of the prostate, Aquablation therapy, Urolift® for benign prostatic enlargement, and blue light cystoscopy for the evaluation and management of bladder cancer. Dr. Michael Chevinsky has partnered to deliver cutting edge expert urologic care at AUCNY Bethpage. Philosophically, Dr. Chevinsky believes in a patient-centered individualized approach, taking into account each person’s unique treatment goals and expectations. He tries to develop long lasting relationships with his patients based on transparency, respect, and mutual trust. After making the West coast-to-East coast trip regularly over a few years to visit family and friends in New York and New Jersey, Dr. Chevinsky made the decision to return home. He enjoys listening to music, attending concerts, and sporting events, playing the piano and saxophone, traveling, cooking, working out, and spending time with his family and his two dogs, Lilo and Hugo, who he rescued from an animal shelter.

Languages Spoken:


Medical School:

Rutgers Robert Wood Johnson Medical School


Washington University in St. Louis


Drew University

All surgical treatments have inherent and associated side effects. Individual’s outcomes may depend on a number of factors, including but not limited to patient characteristics, disease characteristics and/or surgeon experience. The most common side effects are mild and transient and may include mild pain or difficulty when urinating, discomfort in the pelvis, blood in the urine, inability to empty the bladder or a frequent and/or urgent need to urinate, and bladder or urinary tract infection. Other risks include ejaculatory dysfunction and a low risk of injury to the urethra or rectum where the devices gain access to the body for treatment. Further, there may be other risks as in other urological surgery, such as anesthesia risk or the risk of infection, including the potential transmission of blood borne pathogens. For more information about potential side effects and risks associated with Aquablation therapy for Benign Prostatic Hyperplasia (BPH) treatment, speak with your urologist or surgeon. Prior to using our products, please review the Instructions for Use, Operator’s Manual or User Manual, as applicable, and any accompanying documentation for a complete listing of indications, contraindications, warnings, precautions and potential adverse events. No claim is made that the AquaBeam Robotic System will cure any medical condition, or entirely eliminate the diseased entity. Repeated treatment or alternative therapies may sometimes be required.

Rx Only